Literature DB >> 23169671

In vivo directed differentiation of pluripotent stem cells for skeletal regeneration.

Benjamin Levi1, Jeong S Hyun, Daniel T Montoro, David D Lo, Charles K F Chan, Shijun Hu, Ning Sun, Min Lee, Monica Grova, Andrew J Connolly, Joseph C Wu, Geoffrey C Gurtner, Irving L Weissman, Derrick C Wan, Michael T Longaker.   

Abstract

Pluripotent cells represent a powerful tool for tissue regeneration, but their clinical utility is limited by their propensity to form teratomas. Little is known about their interaction with the surrounding niche following implantation and how this may be applied to promote survival and functional engraftment. In this study, we evaluated the ability of an osteogenic microniche consisting of a hydroxyapatite-coated, bone morphogenetic protein-2-releasing poly-L-lactic acid scaffold placed within the context of a macroenvironmental skeletal defect to guide in vivo differentiation of both embryonic and induced pluripotent stem cells. In this setting, we found de novo bone formation and participation by implanted cells in skeletal regeneration without the formation of a teratoma. This finding suggests that local cues from both the implanted scaffold/cell micro- and surrounding macroniche may act in concert to promote cellular survival and the in vivo acquisition of a terminal cell fate, thereby allowing for functional engraftment of pluripotent cells into regenerating tissue.

Entities:  

Mesh:

Year:  2012        PMID: 23169671      PMCID: PMC3528603          DOI: 10.1073/pnas.1218052109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds.

Authors:  Sinae Kim; Sang-Soo Kim; Soo-Hong Lee; Seong Eun Ahn; So-Jung Gwak; Joon-Ho Song; Byung-Soo Kim; Hyung-Min Chung
Journal:  Biomaterials       Date:  2007-11-26       Impact factor: 12.479

Review 2.  ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective.

Authors:  Michela Pozzobon; Marco Ghionzoli; Paolo De Coppi
Journal:  Pediatr Surg Int       Date:  2009-09-01       Impact factor: 1.827

3.  Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation.

Authors:  Feng Cao; Micha Drukker; Shuan Lin; Ahmad Y Sheikh; Xiaoyan Xie; Zongjin Li; Andrew J Connolly; Irving L Weissman; Joseph C Wu
Journal:  Cloning Stem Cells       Date:  2007

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Variation in the safety of induced pluripotent stem cell lines.

Authors:  Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2009-07-09       Impact factor: 54.908

6.  Stem cell therapies benefit Alport syndrome.

Authors:  Valerie LeBleu; Hikaru Sugimoto; Thomas M Mundel; Behzad Gerami-Naini; Elizabeth Finan; Caroline A Miller; Vincent H Gattone; Lingge Lu; Charles F Shield; Judah Folkman; Raghu Kalluri
Journal:  J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 10.121

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

Review 8.  Stem cell sources to treat diabetes.

Authors:  Mark E Furth; Anthony Atala
Journal:  J Cell Biochem       Date:  2009-03-01       Impact factor: 4.429

9.  Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells.

Authors:  Premjit Arpornmaeklong; Shelley E Brown; Zhuo Wang; Paul H Krebsbach
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

10.  Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells.

Authors:  Ning Sun; Nicholas J Panetta; Deepak M Gupta; Kitchener D Wilson; Andrew Lee; Fangjun Jia; Shijun Hu; Athena M Cherry; Robert C Robbins; Michael T Longaker; Joseph C Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-08       Impact factor: 11.205

View more
  51 in total

Review 1.  Stem Cells in Skeletal Tissue Engineering: Technologies and Models.

Authors:  Mark T Langhans; Shuting Yu; Rocky S Tuan
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

2.  Mineralized gelatin methacrylate-based matrices induce osteogenic differentiation of human induced pluripotent stem cells.

Authors:  Heemin Kang; Yu-Ru V Shih; Yongsung Hwang; Cai Wen; Vikram Rao; Timothy Seo; Shyni Varghese
Journal:  Acta Biomater       Date:  2014-08-18       Impact factor: 8.947

Review 3.  Biomimetic polymer scaffolds to promote stem cell-mediated osteogenesis.

Authors:  Eunkyung Ko; Seung-Woo Cho
Journal:  Int J Stem Cells       Date:  2013-11       Impact factor: 2.500

4.  Enhancing in vivo survival of adipose-derived stromal cells through Bcl-2 overexpression using a minicircle vector.

Authors:  Jeong Hyun; Monica Grova; Hossein Nejadnik; David Lo; Shane Morrison; Daniel Montoro; Michael Chung; Andrew Zimmermann; Graham G Walmsley; Min Lee; Heike Daldrup-Link; Derrick C Wan; Michael T Longaker
Journal:  Stem Cells Transl Med       Date:  2013-08-09       Impact factor: 6.940

5.  Engineering bone tissue substitutes from human induced pluripotent stem cells.

Authors:  Giuseppe Maria de Peppo; Iván Marcos-Campos; David John Kahler; Dana Alsalman; Linshan Shang; Gordana Vunjak-Novakovic; Darja Marolt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-07       Impact factor: 11.205

6.  Pharmacological rescue of diabetic skeletal stem cell niches.

Authors:  Ruth Tevlin; Eun Young Seo; Owen Marecic; Adrian McArdle; Xinming Tong; Bryan Zimdahl; Andrey Malkovskiy; Rahul Sinha; Gunsagar Gulati; Xiyan Li; Taylor Wearda; Rachel Morganti; Michael Lopez; Ryan C Ransom; Christopher R Duldulao; Melanie Rodrigues; Allison Nguyen; Michael Januszyk; Zeshaan Maan; Kevin Paik; Kshemendra-Senarath Yapa; Jayakumar Rajadas; Derrick C Wan; Geoffrey C Gurtner; Michael Snyder; Philip A Beachy; Fan Yang; Stuart B Goodman; Irving L Weissman; Charles K F Chan; Michael T Longaker
Journal:  Sci Transl Med       Date:  2017-01-11       Impact factor: 17.956

Review 7.  Induced pluripotent stem cells as a new getaway for bone tissue engineering: A systematic review.

Authors:  Farshid Bastami; Pantea Nazeman; Hamidreza Moslemi; Maryam Rezai Rad; Kazem Sharifi; Arash Khojasteh
Journal:  Cell Prolif       Date:  2016-12-01       Impact factor: 6.831

8.  Surveillance of Stem Cell Fate and Function: A System for Assessing Cell Survival and Collagen Expression In Situ.

Authors:  Graham G Walmsley; Kshemendra Senarath-Yapa; Taylor L Wearda; Siddharth Menon; Michael S Hu; Dominik Duscher; Zeshaan N Maan; Jonathan M Tsai; Elizabeth R Zielins; Irving L Weissman; Geoffrey C Gurtner; H Peter Lorenz; Michael T Longaker
Journal:  Tissue Eng Part A       Date:  2015-12-24       Impact factor: 3.845

9.  Biomineralized matrix-assisted osteogenic differentiation of human embryonic stem cells.

Authors:  Heemin Kang; Cai Wen; Yongsung Hwang; Yu-Ru V Shih; Mrityunjoy Kar; Sung Wook Seo; Shyni Varghese
Journal:  J Mater Chem B       Date:  2014-09-01       Impact factor: 6.331

10.  Cultivation of human bone-like tissue from pluripotent stem cell-derived osteogenic progenitors in perfusion bioreactors.

Authors:  Giuseppe Maria de Peppo; Gordana Vunjak-Novakovic; Darja Marolt
Journal:  Methods Mol Biol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.